Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Basel Medical Group Ltd's Competitiveness

Name: Basel Medical Group Ltd Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Basel Medical Group Ltd (BMGL) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2025

Competitors Tracked

Publicly traded peers

Peer Group Market Share

100.00 %

Share of combined sales, Q4 2025

Revenue Growth Y/Y

Q4 2025

Net Margin

-106.79 %

Q4 2025

Key Findings: Basel Medical Group Ltd vs Its Competitors

TTM: Trailing 12-month revenue of 9M vs -M combined for tracked competitors (100.0% combined share).
Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
Scale: Basel Medical Group Ltd ranks #43 of 51 companies by market capitalization in the Healthcare Facilities industry, holding 0.0% of industry market cap.
Peer revenue share: Basel Medical Group Ltd accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

BMGL Sales vs. its Competitors, Q4 2025

Basel Medical Group Ltd generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/BMGL/competitors                    

                        https://api.csimarket.com/api/v1/companies/BMGL/relationships                    

                        https://api.csimarket.com/api/v1/companies/BMGL/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

Basel Medical Group Ltd's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Basel Medical Group Ltd	-	-	-	-
Similar-Size Competitors (10)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

BMGL Stock Performance relative to its Competitors

BMGL Competitors (weighted) Percent change over the selected range

Basel Medical Group Ltd's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.

Similar-Size
(1 of 4)

Entity	TTM Share Price Return (group: median)	vs U.S.A. 500
Basel Medical Group Ltd	-	-
Competitors combined (0)	40.4%	63.2%
High-Confidence Competitors (0)	40.4%	63.2%
Similar-Size Competitors (4)	40.4%	63.2%
Similar Growth & Profitability (0)	40.4%	63.2%

Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Basel Medical Group Ltd's competitor groups requires a Commercial License.

Unlock Commercial Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

BMGL Stock Performance relative to Similar-Size Competitors

BMGL Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Basel Medical Group Ltd's Comment on Competition and Industry Peers

The company operates in a highly competitive healthcare sector, facing competition from government-owned hospitals, private hospitals, medical centers, and clinics. Competitors may have longer operating histories, greater financial and personnel resources, and may offer lower pricing, exerting pricing pressures. Some competitors also plan to expand their facilities, potentially increasing competition. This environment may affect the company's patient volumes and competitive position, particularly if it does not provide quality medical services or if its charges exceed those of competitors.